NCT02800148View on ClinicalTrials.gov

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

PHASE3CompletedINTERVENTIONAL

Enrollment

667

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

Rosacea

Interventions

DRUG

Azelaic acid foam

DRUG

Azelaic acid foam

DRUG

Azelaic acid foam - Placebo

Trial Locations (1)

27262

Dermatology Consultants, High Point

Sponsors

Lead Sponsor

Collaborators (1)

DPT Laboratories, Ltd.

All Listed Sponsors

collaborator

DPT Laboratories, Ltd.

INDUSTRY

lead

Padagis LLC

INDUSTRY

NCT02800148 - Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face | Biotech Hunter | Biotech Hunter